Published in Women's Health Weekly, October 19th, 2006
"It has been hypothesized that breast cancer risk is influenced by prenatal hormone levels. Diethylstilbestrol (DES), a synthetic estrogen, was widely used by pregnant women in the 1950s and 1960s. Women who took the drug have an increased risk of breast cancer, but whether risk is also increased in the daughters who were exposed in utero is less clear," stated investigators in the United States.
J.R. Palmer and colleagues of Boston University assessed "the relation of prenatal DES exposure to risk of breast cancer in a cohort of DES-exposed and unexposed women...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly